Contraception with a Vaginal Ring Releasing 3-Keto Desogestrel and Ethinylestradiol
Sven‐Eric Olsson, Viveca Odlind
Abstract
Sven‐Eric Olsson, Viveca Odlind
Abstract
Abstract Eleven healthy women used a contraceptive vaginal ring for three cycles. The rings released 15 μg of ethinylestradiol and 150 μg of 3-keto desogestrel per 24 hours. The rings were used for 21 days and then removed, rinsed in clean water and stored. After a 7-day ring-free period, the rings were reinserted. Totally, each ring was used for 3 cycles. The rings were well tolerated. The bleeding pattern was excellent. No woman showed any signs of ovulation when using the ring. Estradiol levels were suppressed, but showed an increase during the ring-free period as can be found during the pill-free period of an oral contraceptive regimen. When the ring was reinserted, the estradiol levels were rapidly suppressed again. SHBG capacity increased during use of the ring.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Eleven healthy women used a contraceptive vaginal ring for three cycles. The rings released 15 μg of ethinylestradiol and 150 μg of 3-keto desogestrel per 24 hours. The rings were used for 21 days and then removed, rinsed in clean water and stored. After a 7-day ring-free period, the rings were reinserted. Totally, each ring was used for 3 cycles. The rings were well tolerated. The bleeding pattern was excellent. No woman showed any signs of ovulation when using the ring. Estradiol levels were suppressed, but showed an increase during the ring-free period as can be found during the pill-free period of an oral contraceptive regimen. When the ring was reinserted, the estradiol levels were rapidly suppressed again. SHBG capacity increased during use of the ring.
Key concepts: Desogestrel, Vaginal ring, Medicine, Ethinylestradiol, Ovulation, Ring (chemistry), Pill, Etonogestrel